From traditional Chinese medicine to rational cancer therapy

被引:464
作者
Efferth, Thomas
Li, Paul C. H.
Konkimalla, Venkata S. Badireenath
Kaina, Bernd
机构
[1] German Canc Res Ctr, Pharmaceut Biol C015, D-69120 Heidelberg, Germany
[2] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[3] Johannes Gutenberg Univ Mainz, Inst Toxicol, D-55131 Mainz, Germany
关键词
D O I
10.1016/j.molmed.2007.07.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many natural products and derivatives thereof belong to the standard repertoire of cancer chemotherapy. Examples are Vinca alkaloids, taxanes and camptothecins. In recent years, the potential of natural products from plants, notably from medicinal plants used in traditional Chinese medicine (TCM), has been recognized by the scientific community in the Western world. To provide an example of the most recent developments in this field, we have selected several compounds, namely artesunate, homoharringtonine, arsenic trioxide and cantharidin, that are found in natural TCM products and that have the potential for use in cancer therapy. Controlled clinical studies have shown that homoharringtonine and arsenic trioxide can exert profound activity against leukaemia. Increased knowledge of the molecular mechanisms of TCM-derived drugs and recent developments in their applications demonstrate that the combination of TCM with modern cutting-edge technologies provides an attractive strategy for the development of novel and improved cancer therapeutics.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 78 条
[1]   MEDICINE FROM PLANTS [J].
ABELSON, PH .
SCIENCE, 1990, 247 (4942) :513-513
[2]  
AJANI JA, 1986, CANCER TREAT REP, V70, P375
[3]   Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer [J].
Arlt, VM ;
Alunni-Perret, V ;
Quatrehomme, G ;
Ohayon, P ;
Albano, L ;
Gaïd, H ;
Michiels, JF ;
Meyrier, A ;
Cassuto, E ;
Wiessler, M ;
Schmeiser, HH ;
Cosyns, JP .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) :977-980
[4]   Aristolochic acid as a probable human cancer hazard in herbal remedies: a review [J].
Arlt, VM ;
Stiborova, M ;
Schmeiser, HH .
MUTAGENESIS, 2002, 17 (04) :265-277
[5]   A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study [J].
Bell, BA ;
Chang, MN ;
Weinstein, HJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (02) :103-107
[6]  
Berger TG, 2005, ONCOL REP, V14, P1599
[7]   Immunoprecipitation of [3H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies [J].
Bhisutthibhan, J ;
Meshnick, SR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2397-2399
[8]   Telomerase and telomere dynamics in ageing and cancer:: current status and future directions [J].
Camarena, F. Sampedro ;
Serral, G. Cano ;
Santalo, F. Sampedro .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (03) :145-154
[9]   Arsenic trioxide: New clinical experience with an old medication in hematologic malignancies [J].
Douer, D ;
Tallman, MS .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2396-2410
[10]  
Duflos Alain, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P55, DOI 10.2174/1568011023354452